Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance (in shares) at Dec. 31, 2021			155,137,237
Beginning balance at Dec. 31, 2021	$ 168,767	$ 0	$ 16	$ 320,937	$ (391)	$ (151,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,340			5,340
Issuance of common stock upon exercise of stock options (in shares)			656,303
Issuance of common stock upon exercise of stock options	222			222
Issuance of common stock upon vesting of restricted stock units (in shares)			856,917
Taxes related to net share settlement of equity awards (in shares)			(285,533)
Taxes related to net share settlement of equity awards	(1,149)			(1,149)
Unrealized loss on available-for-sale securities	(1,056)				(1,056)
Net loss	(24,881)					(24,881)
Ending balance (in shares) at Mar. 31, 2022			156,364,924
Ending balance (in shares) at Mar. 31, 2022		0
Ending balance at Mar. 31, 2022	$ 147,243	$ 0	$ 16	325,350	(1,447)	(176,676)
Beginning balance (in shares) at Dec. 31, 2022	0	0
Beginning balance (in shares) at Dec. 31, 2022	163,099,124		163,099,124
Beginning balance at Dec. 31, 2022	$ 93,970	$ 0	$ 16	345,742	(1,279)	(250,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,513			6,513
Issuance of common stock upon exercise of stock options (in shares)			2,069,081
Issuance of common stock upon exercise of stock options	391			391
Issuance of common stock upon vesting of restricted stock units (in shares)			2,983,790
Taxes related to net share settlement of equity awards (in shares)			(1,320,828)
Taxes related to net share settlement of equity awards	(867)			(867)
Conversion of convertible note into common stock (in shares)			4,138,414
Conversion of convertible note into common stock	1,755		$ 1	1,754
Other comprehensive income, net of tax	469				469
Unrealized loss on available-for-sale securities	490
Net loss	$ (26,265)					(26,265)
Ending balance (in shares) at Mar. 31, 2023	170,969,581		170,969,581
Ending balance (in shares) at Mar. 31, 2023	0	0
Ending balance at Mar. 31, 2023	$ 75,966	$ 0	$ 17	$ 353,533	$ (810)	$ (276,774)